Position in PFE
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$557,427
-$167,962 QoQ
Shares Held
23,149
-10.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#1,681
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ADIRONDACK TRUST CO holds $16,941,363 across 11 Drug Manufacturers - General names. PFE ranks #7 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
19,692 | $5,001,176 | |
| 2 | LLY |
ELI LILLY & Co
|
3,642 | $4,368,324 | |
| 3 | ABBV |
AbbVie Inc.
|
13,727 | $3,454,261 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
19,711 | $1,135,747 | |
| 5 | MRK |
Merck & Co., Inc.
|
8,753 | $1,124,760 | |
| 6 | AMGN |
Amgen Inc
|
2,529 | $915,801 | |
| 7 | PFE |
Pfizer Inc
This page
|
23,149 | $557,427 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,872 | $236,508 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $557,427 | 23,149 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $725,389 | 25,833 | Shares | Sole | 2026-04-03 | |
| 2025-12-31 | $678,574 | 27,252 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $738,358 | 28,978 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $803,385 | 33,143 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $955,722 | 37,716 | Shares | Sole | 2025-04-03 | |
| 2024-12-31 | $1,109,086 | 41,805 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $1,562,527 | 53,992 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $1,546,370 | 55,267 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $1,538,903 | 55,456 | Shares | Sole | 2024-04-09 | |
| 2023-12-31 | $1,601,327 | 55,621 | Shares | Sole | 2024-03-29 | |
| 2023-09-30 | $1,901,801 | 57,335 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $2,063,910 | 56,268 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,301,976 | 56,421 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $2,884,914 | 56,302 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $2,700,210 | 61,705 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $3,213,382 | 61,289 | Shares | Sole | 2022-07-06 | |
| 2022-03-31 | $2,271,460 | 43,876 | Shares | Sole | 2022-04-05 | |
| 2021-12-31 | $2,406,700 | 40,757 | Shares | Sole | 2022-01-13 | |
| 2021-09-30 | $1,726,292 | 40,137 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,445,238 | 36,906 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $1,320,909 | 36,459 | Shares | Sole | 2021-04-16 | |
| 2020-12-31 | $1,217,269 | 33,069 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,125,917 | 30,679 | Shares | Sole | 2020-10-05 | |
| 2020-06-30 | $1,006,147 | 30,769 | Shares | Sole | 2020-08-19 | |
| 2020-03-31 | $841,065 | 25,768 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||